| Craig D Butler Ii, MD | |
|
222 Medical Circle, Morehead, KY 40351-1179 | |
| (606) 783-6500 | |
| Not Available |
| Full Name | Craig D Butler Ii |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 25 Years |
| Location | 222 Medical Circle, Morehead, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033119839 | NPI | - | NPPES |
| 000000341155 | Other | KY | BC/BS INDIVIDUAL PIN NO |
| 64082407 | Medicaid | KY | |
| P00139356 | Other | KY | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 35797 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Claire Regional Medical Center | Morehead, KY | Hospital |
| University Of Kentucky Hospital | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Claire Medical Center Inc | 4486559085 | 120 |
News Archive
Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
Henry Ford Health System is the first in the country to perform a procedure using the CG-100™ intraluminal device, which is temporarily inserted into the gastrointestinal tract and designed to reduce diverting stoma rates, and the need for an ostomy bag, in patients undergoing gastrointestinal resection procedures due to colorectal cancer treatment.
Well more than a million patients are transferred between hospitals each year in the U.S. This process is challenging both for hospitals and patients and breakdowns in communication are common.
BD, a leading global technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers.
› Verified 5 days ago
| Entity Name | St. Claire Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821168535 PECOS PAC ID: 4486559085 Enrollment ID: O20031205000579 |
News Archive
Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
Henry Ford Health System is the first in the country to perform a procedure using the CG-100™ intraluminal device, which is temporarily inserted into the gastrointestinal tract and designed to reduce diverting stoma rates, and the need for an ostomy bag, in patients undergoing gastrointestinal resection procedures due to colorectal cancer treatment.
Well more than a million patients are transferred between hospitals each year in the U.S. This process is challenging both for hospitals and patients and breakdowns in communication are common.
BD, a leading global technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers.
› Verified 5 days ago
| Entity Name | Foundation Radiology Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740482686 PECOS PAC ID: 3779683537 Enrollment ID: O20140808000950 |
News Archive
Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
Henry Ford Health System is the first in the country to perform a procedure using the CG-100™ intraluminal device, which is temporarily inserted into the gastrointestinal tract and designed to reduce diverting stoma rates, and the need for an ostomy bag, in patients undergoing gastrointestinal resection procedures due to colorectal cancer treatment.
Well more than a million patients are transferred between hospitals each year in the U.S. This process is challenging both for hospitals and patients and breakdowns in communication are common.
BD, a leading global technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers.
› Verified 5 days ago
| Entity Name | Highlands Hospital And Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447443957 PECOS PAC ID: 2769460757 Enrollment ID: O20210823001042 |
News Archive
Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
Henry Ford Health System is the first in the country to perform a procedure using the CG-100™ intraluminal device, which is temporarily inserted into the gastrointestinal tract and designed to reduce diverting stoma rates, and the need for an ostomy bag, in patients undergoing gastrointestinal resection procedures due to colorectal cancer treatment.
Well more than a million patients are transferred between hospitals each year in the U.S. This process is challenging both for hospitals and patients and breakdowns in communication are common.
BD, a leading global technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Craig D Butler Ii, MD 222 Medical Circle, Morehead, KY 40351-1179 Ph: (606) 783-6500 | Craig D Butler Ii, MD 222 Medical Circle, Morehead, KY 40351-1179 Ph: (606) 783-6500 |
News Archive
Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
Henry Ford Health System is the first in the country to perform a procedure using the CG-100™ intraluminal device, which is temporarily inserted into the gastrointestinal tract and designed to reduce diverting stoma rates, and the need for an ostomy bag, in patients undergoing gastrointestinal resection procedures due to colorectal cancer treatment.
Well more than a million patients are transferred between hospitals each year in the U.S. This process is challenging both for hospitals and patients and breakdowns in communication are common.
BD, a leading global technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers.
› Verified 5 days ago
Robert Clell Miller Jr., MD Radiology Medicare: Medicare Enrolled Practice Location: 228 W 2nd St, Morehead, KY 40351 Phone: 606-784-3443 | |
Dr. Stephen Arnold Williams, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 859-608-9093 | |
William D Lewis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 | |
Mircea B Lipovan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 |